Brought to you by:
French study: Third-gen Anaconda endograft indicates satisfactory five-year exclusion
The third-generation Anaconda endograft from Terumo Aortic provides “high technical success” as well as “satisfactory” five-year aneurysm exclusion and clinical success rates, a French multicenter prospective observational study has found. The investigators note that longer-term results with new generation endografts are “essential” due to a…
Patients with large AAAs see higher five-year mortality with EVAR compared to open repair
Large abdominal aortic aneurysm (AAA) repair is associated with higher adjusted five-year mortality, reintervention and rupture rates after endovascular aneurysm repair (EVAR)—but not after open repair, a prize-winning paper at the recently concluded SVS ONLINE digital conference concluded. Nevertheless, an…
International Lecture: Endovascular colossus discusses new PAD therapy
A new therapy of hydration and oncotic pressure of plasma helped 100% of certain elderly peripheral artery disease (PAD) patients in terms of pain, ankle-brachial index (ABI) and walking time, endovascular pioneer Juan C. Parodi, MD, said on Tuesday, June…
Paper on EVAR for large AAAs named 2020 poster winner
Livia de Guerre, MD, of Beth Israel Deaconess Medical Center in Boston has been named winner of this year’s poster contest. This year’s contest was held virtually as part of SVS ONLINE: “New Advances and Discoveries in Vascular Surgery.” She…
Vascular pioneer to present International Lecture next week
Renowned endovascular pioneer Juan C. Parodi, MD, will present the International Lecture at this year’s SVS ONLINE virtual meeting. He will deliver his address, “Treating intermittent claudication and rest pain: A new approach,” from 6:05 to 6:20 p.m. Central Daylight…
Study: Decreased complication among EVAR conversion patients anticipated when managed at high-volume aortic centers
Endovascular aortic aneurysm repair (EVAR) conversion to open aortic repair (OAR) is now an increasingly common indication and associated with greater operative complexity. However, “decreased complication risk and comparable survival can be anticipated when patients are managed at high-volume aortic…
Nearly 70% of CX 2020 LIVE global aortic audience finds type II endoleak without sac expansion harmless
A global audience tuned into the second session and inaugural aortic offering of CX 2020 LIVE. With registrations now well over 4,000, the pioneering virtual vascular conference continues to attract delegates from far and wide. In this session, presentations, polling and…
Terumo Aortic gains FDA approval for Treo endovascular device
Terumo Aortic has been granted Food and Drug Administration (FDA) approval for the Treo abdominal aortic stent-graft system to be sold in the U.S. The Treo, used in the treatment of patients with abdominal aortic aneurysms (AAA), is the only…
‘Excellent’ long-term results after EVAR using Endurant stent graft in 180 AAA patients
Results from a real-world experience over more than 10 years using the Endurant stent graft (Medtronic) demonstrate that it is safe and effective, with excellent long-term outcomes for abdominal aortic aneurysm (AAA) anatomy that falls both inside and outside instructions…
Open AAA repair volume appears to be more impactful on outcomes than years of experience, investigators reveal
PALM BEACH, Fla.— The more open aortic repair (OAR) case volume vascular surgeons take on, the more it seems to be “impactful” on OAR outcomes than a physician’s accumulated years of practice experience. The finding was revealed by Salvatore T.…